Jagsonpal Pharmaceuticals informs about press release

16 Aug 2021 Evaluate

In terms of regulation 30 of the SEBI (LODR) Regulations, 2015, Jagsonpal Pharmaceuticals has informed that it enclosed a copy of the Press Release on the Unaudited Financial results of the Company for the quarter ended 30th June, 2021.

The above information is a part of company’s filings submitted to BSE.

Jagsonpal Pharma Share Price

640.20 48.55 (8.21%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.